AliveCor, Inc., an Oklahoma City-based developer of a mobile electrocardiogram recorder, has secured $3m in Series A financing.
The round was led by Burrill & Company, with participation from Qualcomm Ventures and the Oklahoma Life Science Fund.
The company intends to use the funds to to expand its team, complete clinical studies currently ongoing at the Oklahoma University Health Sciences Center, pursue regulatory approvals, and launch its iPhone ECG and Android iCard ECG worldwide.
Led by founder and President Dr. David Albert, AliveCor has developed a clinical-quality low-cost ECG recorder designed to work in conjunction with a variety of mobile platforms, including iPhone, iPad, and Android devices.
In conjunction with the funding, Bryant Fong and Dirk Lammerts, both Managing Directors at Burrill & Company, will join the companys’ Board of Directors.
The AliveCor ECG is not cleared as a medical device in the US and is currently not available for sale.